
Cost savings in diabetes cannot come at the expense of quality. This is a part of the story that wasn’t clearly conveyed in the NY Times article. Read an open letter from Manny Hernandez to the New York Times.
Read more
Cost savings in diabetes cannot come at the expense of quality. This is a part of the story that wasn’t clearly conveyed in the NY Times article. Read an open letter from Manny Hernandez to the New York Times.
Read more